Trials / Conditions / Glaucoma, Primary Open Angle

Glaucoma, Primary Open Angle

27 registered clinical trials studyying Glaucoma, Primary Open Angle — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients NCT04007276	Tulane University	Phase 4
Completed	Treating Psychosocial Distress in Glaucoma NCT06053307	Duke University	N/A
Recruiting	Safety and Feasibility of the ELIOS System in POAG Patients NCT05999006	Elios Vision, Inc.	N/A
Unknown	Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia NCT05964634	Zhongshan Ophthalmic Center, Sun Yat-sen University	—
Unknown	Glaucoma Assessment Via Reading Ability NCT05673954	Peking University	—
Completed	Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients NCT05181046	Nanodropper, Inc.	N/A
Completed	Excimer Laser Trabeculostomy Glaucoma Treatment Study NCT04899063	Elios Vision, Inc.	N/A
Completed	The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA NCT05474716	Fayoum University	Phase 4
Completed	Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert NCT04465864	Wolstan and Goldberg Eye Associates	Phase 4
Completed	Safety and IOP-Lowering Effects of WB007 NCT04149899	Bausch & Lomb Incorporated	Phase 1 / Phase 2
Recruiting	Caffeine Consumption in Glaucoma Patients and Healthy Subjects NCT03675412	Wills Eye	N/A
Unknown	UCP (Ultrasound Cyclo Plasty) in the Treatment of Chinese Patients With Primary Open-angle Glaucoma NCT04321122	Zhongshan Ophthalmic Center, Sun Yat-sen University	N/A
Completed	Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Gla NCT04737928	Santen Pharmaceutical (Taiwan) Co., LTD	N/A
Recruiting	Adaptive Optics Retinal Imaging NCT05370287	Food and Drug Administration (FDA)	N/A
Unknown	Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily NCT03067415	Chong Kun Dang Pharmaceutical	Phase 2
Unknown	LSFG in Patients With Normal Tension Glaucoma Tension Glaucoma NCT03318510	Augenabteilung Allgemeines Krankenhaus Linz	N/A
Terminated	Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Ope NCT02858284	EyeSonix	N/A
Completed	Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hyperte NCT02796560	Université de Sherbrooke	Phase 4
Unknown	Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent NCT03151577	Swiss Vision Network	N/A
Unknown	Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glauco NCT02679482	Fundación Oftalmológica Nacional	—
Completed	A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a M NCT01999348	Allergan	—
Completed	A Study of Bimatoprost 0.01% in the Clinical Setting NCT01814761	Allergan	—
Completed	A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherap NCT01853085	Allergan	—
Completed	NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement NCT01408472	Jeffrey L Goldberg	Phase 1
Completed	Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle NCT01737853	Allergan S.A. DE C.V..	—
Completed	Assessment of Effectiveness Ex-Press Surgery Modification NCT03800589	Military Institute od Medicine National Research Institute	N/A
Completed	A Study of LUMIGAN® RC in the Clinical Setting NCT01833741	Allergan	Phase 4